Combination therapy for pain in musculoskeletal diseases
https://doi.org/10.14412/2074-2711-2012-427
Abstract
References
1. <div><p>Ревматология. Клинические рекомендации. Под ред. акад. Е.Л. Насонова. М.: ГЭОТАР-Медиа, 2010;752 с.</p><p>Насонов Е.Л., Насонова В.А. Фармакотерапия боли: взгляд ревматолога. Cons med 2000;2(12):7-14.</p><p>Боль (практическое руководство для врачей). Под ред. Н.Н. Яхно, М.Л. Кукушкина. М.: Изд-во РАМН, 2012;512 c.</p><p>Nüesch E., Dieppe P., Reichenbach S. et al. All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ 2011;342:d1165. doi: 10.1136/bmj.d1165.</p><p>Tsuboi M., Hasegawa Y., Matsuyama Y. et al. Do musculoskeletal degenerative diseases affect mortality and cause of death after 10 years in Japan? J Bone Miner Metab 2011;29(2):217-23.</p><p>Zhu K., Devine A., Dick I. et al. Association of back pain frequency with mortality, coronary heart events, mobility, and quality of life in elderly women. Spine 2007;32(18):2012—8.</p><p>Arboleya L., de la Figuera E., Soledad Garcia M. et al. Management pattern for patients with osteoarthritis treated with traditional non steroidal anti-inflammatory drugs in Spain prior to introduction of Coxibs. Curr Med Res Opin 2003;19(4):278-87.</p><p>Gore M., Sadosky A., Leslie D. et al. Therapy Switching, Augmentation, and Discontinuation in Patients with Osteoarthritis and Chronic Low Back Pain. Pain Pract 2012;12(6):457-68.</p><p>Чичасова Н.В. Проблема боли при остеоартрозе. Леч врач 2007;2:18-25</p><p>Bianchi M., Martucci C., Ferrario P. et al. Increased Tumor Necrosis Factor- and Prostaglandin E2 Concentrations in the Cerebrospinal Fluid of Rats with Inflammatory Hyperalgesia: The Effects of Analgesic Drugs. Anest Analg 2007;104:949-54.</p><p>McCrory C., Fitzgerald D. Spinal prostaglandin formation and pain perception following thoracotomy: a role for cyclooxyge-nase-2. Chest 2004;125(4):1321-7.</p><p>Tassorelli C., Greco R., Sandrini G. et al. Central components of the analgesic/antihyperalgesic effect of nimesulide: studies in animal models of pain and hyperalgesia. Drugs 2003;63(Suppl 1):9—22.</p><p>Dembo G., Park S., Kharasch E. Central nervous system concentrations of cyclooxygenase-2 inhibitors in humans. Anesthesiology 2005;102(2):409-15.</p><p>Каратеев А.Е., Яхно Н.Н., Лазебник Л.Б. и др. Применение нестероидных противовоспалительных препаратов. Клинические рекомендации. М.: ИМА-ПРЕСС, 2009;167 с.</p><p>De Oliveira G., Agarwal D., Benzon H. Perioperative Single Dose Ketorolac to Prevent Post-operative Pain: A Meta-Analysis of Randomized Trials. Anesth Analg 2012;114(2):424—33.</p><p>Gillis J., Brogden R. Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetics and therapeutics use in pain management. Drug 1997;53:139-88</p><p>Martin Carrasco C., Rodriquez Vasquez M., Palacios Garsia R. A double-blind study of analgesic efficacy in kidney colic of the combination of dipyrone and spasmolytic with ketorolac trometamol. Arch Esp Urol 1993;46:763-8.</p><p>Marin-Bertolin S., de Andres J., Gonzalez-Martinez R. et al. A controlled, randomized, double-blind study of ketorolac for postoperative analgesia after plastic surgery. Ann Plast Surg 1997;38:478-84.</p><p>Gonzalez-Garcia C.A., Ibarra-Ibarra L.G., Barbosa-Vivanco S. Comparative study of ketoralac and dipyrone administered orally in the treatment of postoperative pain. Proc West Pharacol Soc 1994;37:121-2 (abstr).</p><p>Меладзе З.А., Гунько В.И., Бутров А.В. Применение НПВП в амбулаторной хирургической стоматологии. Тезисы конференции «Клинические и теоретические аспекты боли», М., 2001.</p><p>Верткин А.А., Вовк Е.И., Наумов А.В. и др. Некоторые вопросы дифференциального назначения лекарственных препаратов для терапии острой боли. www.intensive.ru</p><p>Галушко Е.А., Зоткин Е.Г., Салихов И.Г. и др. Клиническая эффективность и пере носимость НПВП при остеоартрозе с выраженным болевым синдромом. Леч врач 2008;4:32-8.</p><p>Forrest J., Camu F., Greer I.A. Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery. British J Anaesth 2002;88:227-33.</p><p>В.Г. Барскова. Письмо редактора. Совр ревматол 2011;2:82-3.</p><p>Mattia C., Ciarcia S., Muhindo A. et al. Nimesulide: 25 years later. Minerva Med 2010;101(4):285-93.</p><p>Насонов Е.Л. Эффективность и переносимость нестероидного противовоспалительного препарата. Нимесулид: новые данные. РМЖ 2001;15:6-8.</p><p>Rainsford K. Current status of the therapeutic uses and actions of the preferential cyclo-oxygenase-2 NSAID, nimesulide. Inflammopharmacology 2006;14(3—4):120—37.</p><p>Bennett A. Nimesulide a well established cyclooxygenase-2 inhibitor with many other pharmacological properties relevant to inflammatory diseases. In: Therapeutic Roles of Selective COX-2 Inhibitors. J.R. Vein, R.M. Botting (eds). London: William Harvey Press, 2001;524-40.</p><p>Bradbury F. How important is the role of the physician in the correct use of a drug? An observational cohort study in general practice. Int J Clin Pract (Suppl) 2004;144:27-32.</p><p>Conforti A., Leone R., Moretti U. et al. Adverse drug reactions related to the use of NSAIDs with a focus on nimesulide: results of spontaneous reporting from a Northern Italian area. Drug Saf 2001;24:1081-90.</p><p>Laporte J., Ibanez L., Vidal X. et al. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Saf 2004;27:411-20.</p><p>Helin-Salmivaara A., Virtanen A., Veslainen R. et al. NSAID use and the risk of hospitalisation for first myocardial infarction in the general population: a national case-control study from Finland. Eur Heart 2006;27:1657-63.</p><p>Каратеев А.Е. Российский опыт применения нимесулида: обзор клинических испытаний. Cons med 2011;13(9):89-95.</p><p>Каратеев А.Е., Алексеева Л.И., Братыгина Е.А. и др. Оценка частоты развития побочных эффектов при длительном применении нимесулида в реальной клинической практике. РМЖ 2009;17(21):1466-72.</p><p>Каратеев А.Е., Насонова В.А. Развитие и рецидивирование язв желудка и двенадцатиперстной кишки у больных, принимающих нестероидные противовоспалительные препараты: влияние стандартных факторов риска. Тер арх 2008;5:62-6.</p><p>Fitzcharles M., Lussier D., Shir Y. Management of chronic arthritis pain in the elderly. Drugs Aging 2010;27(6):471—90.</p><p>Ong C., Seymour R., Lirk P. et al. Combining paracetamol (acetaminophen) with nonsteroidal antiinflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain. Anesth Analg 2010;110(4): 1170-9.</p><p>Pavelka K., Peliskova Z., Stehlikova H. et al. Intraindividual differences in pain relief and functional improvement in osteoarthritis with diclofenac or tramadol. Clin Drug Investig 1998;16(6):421-9.</p><p>O’Donnell J., Ekman E., Spalding W. et al. The effectiveness of a weak opioid medication versus a cyclo-oxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug in treating flare-up of chronic low-back pain: results from two randomized, double-blind, 6-week studies. J Int Med Res 2009;37(6):1789-802.</p><p>Cepeda M., Camargo F., Zea C. et al. Tramadol for osteoarthritis: a systematic review and metaanalysis. J Rheum 2007;34(3):543-55.</p><p>Emkey R., Rosenthal N., Wu S. et al. Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial. J Rheum 2004;31(1):150-6.</p><p>Beebe F., Barkin R., Barkin S. A clinical and pharmacologic review of skeletal muscle relaxants for musculoskeletal conditions. Am J Ther 2005;12(2):151-71.</p><p>Richards B., Whittle S., van der Heijde D. et al. The Efficacy and Safety of Muscle Relaxants in Inflammatory Arthritis: A Cochrane Systematic Review. J Rheum Suppl 2012;90:34-9.</p><p>Richards B., Whittle S., van der Heijde D. et al. Efficacy and Safety of Neuromodulators in Inflammatory Arthritis: A Cochrane Systematic Review. J Rheum Suppl 2012;90:28-33.</p><p>Richards B., Whittle S., van der Heijde D. et al. Efficacy and Safety of Antidepressants in Inflammatory Arthritis: A Cochrane Systematic Review. J Rheum Suppl 2012;90:21-7.</p><p>Van Tulder M., Touray T., Furlan A. et al. Muscle relax ants for non-specific low back pain. Cochrane Database Syst Rev 2003;(2):CD004252.</p><p>Berry H., Hutchinson D. A multicentre placebo-controlled study in general practice to evaluate the efficacy and safety of tizanidine in acute low-back pain. J Int Med Res 1988;16(2):75-82.</p><p>Berry H., Hutchinson D. Tizanidine and ibuprofen in acute low-back pain: results of a double-blind multicentre study in general practice. J Int Med Res 1988;16(2):83—91.</p><p>Sirdalud Ternilin Asia-Pacific Study group. Efficacy and gastroprotective effects of tizanidine plus diclofenac versus placebo plus diclofenac in patients with painful muscle spasm. Curr Ther Res 1998;59:13-22.</p><p>Pareek A., Chandurkar N., Chandanwale A. et al. Aceclofenac-tizanidine in the treatment of acute low back pain: a double-blind, doubledummy, randomized, multicentric, comparative study against aceclofenac alone. Eur Spine J 2009;18(12):1836-42.</p><p>Данилов А.Б. Возможности применения тизанидина (Сирдалуда) в клинической практике. РМЖ 2009;17(19):1-7.</p></div><br />
Review
For citations:
Karateev AE. Combination therapy for pain in musculoskeletal diseases. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2012;4(4):76-83. (In Russ.) https://doi.org/10.14412/2074-2711-2012-427